Why Fiducian Group, Northern Star, Paradigm, and Santos shares are charging higher

These shares are avoiding the market sell-off.

| More on:
Man drawing an upward line on a bar graph symbolising a rising share price.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is having another day to forget on Friday. In afternoon trade, the benchmark index is down 1.45% to 7,532.3 points.

Four ASX shares that are not letting that hold them back today and are avoiding the market selloff are listed below. Here's why they are rising:

Fiducian Group Ltd (ASX: FID)

The Fiducian Group share price is up 6% to $8.04. This follows the release of an update from the financial services company. The company revealed that net inflows to the core Fiducian platform for the quarter ending 31 March 2024 were $53 million. This brings its year to date net inflows to $139 million. This means that the company's funds under management, administration and advice were $13.7 billion at the end of March. This is up 11.4% year on year from $12.3 billion.

Northern Star Resources Ltd (ASX: NST)

The Northern Star share price is up 4% to $15.90. Investors have been buying Northern Star and other gold miners today after investors rotated out of risk assets and into risk off/safe haven assets. This has been driven by reports claiming that Israel has retaliated to the recent Iranian attacks with strikes of its own. Demand has been so strong for safe haven assets that the S&P/ASX All Ordinaries Gold index is up almost 3% this afternoon.

Paradigm Biopharmaceuticals Ltd (ASX: PAR)

The Paradigm Biopharmaceuticals share price is up 3.5% to 29.5 cents. This morning, this biopharmaceuticals company announced the submission of key documents to the US Food and Drug Agency (FDA) for review and agreement on the progression of the phase 3 clinical program in osteoarthritis. Paradigm's managing director, Paul Rennie, commented: "This is important progress for Paradigm as we deliver a significant amount of new data to the US FDA for review to progress to the next stage of the phase 3 OA program."

Santos Ltd (ASX: STO)

The Santos share price is up 3% to $7.93. This has also been driven by news that Israel has retaliated and attacked Iranian sites with missiles. In response to the news, oil prices have jumped almost 4% amid concerns that this could disrupt oil supply in the region. According to CNBC, at the time of writing, the WTI crude oil price is up 4% to US$86.06 a barrel and the Brent crude oil price is up 3.9% to US$90.50 a barrel. The S&P/ASX 200 Energy index is up 0.8% in afternoon trade.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Fiducian Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »